Amiodarone's role in simvastatin-associated rhabdomyolysis.
D000638:Amiodarone / Q000009:adverse effects* / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D051544:Cytochrome P-450 CYP3A; D065607:Cytochrome P-450 Enzyme Inhibitors; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006801:Humans; D012206:Rhabdomyolysis / Q000139:chemically induced*; D019821:Simvastatin / Q000008:administration & dosage / Q000009:adverse effects*
D000924:Anticholesteremic Agents; D065607:Cytochrome P-450 Enzyme Inhibitors; D019821:Simvastatin; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A; D000638:Amiodarone